(Q40808798)

English

Changes over time in the impact of gene-expression profiles on the administration of adjuvant chemotherapy in estrogen receptor positive early stage breast cancer patients: A nationwide study

scientific article published on 8 April 2016

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Changes over time in the impact of gene-expression profiles on the administration of adjuvant chemotherapy in estrogen receptor positive early stage breast cancer patients: A nationwide study (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

author name string

A Kuijer

1

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

C A Drukker

2

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

S G Elias

3

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

C H Smorenburg

4

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

E J Th Rutgers

5

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

S Siesling

6

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Th van Dalen

7

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

language of work or name

0 references

publication date

8 April 2016

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

International Journal of Cancer

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

139

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

769-775

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

1 reference

https://api.crossref.org/works/10.1002%2FIJC.30132

21 January 2018

Meeting highlights: International Consensus Panel on the Treatment of Primary Breast Cancer. Seventh International Conference on Adjuvant Therapy of Primary Breast Cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.30132

21 January 2018

Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.30132

21 January 2018

A gene-expression signature as a predictor of survival in breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.30132

21 January 2018

A prospective evaluation of a breast cancer prognosis signature in the observational RASTER study

1 reference

https://api.crossref.org/works/10.1002%2FIJC.30132

21 January 2018

Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.30132

21 January 2018

Long-term impact of the 70-gene signature on breast cancer outcome

1 reference

https://api.crossref.org/works/10.1002%2FIJC.30132

21 January 2018

Strategies for subtypes--dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011

1 reference

https://api.crossref.org/works/10.1002%2FIJC.30132

21 January 2018

Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

1 reference

https://api.crossref.org/works/10.1002%2FIJC.30132

21 January 2018

Uses of cancer registries for public health and clinical research in Europe: Results of the European Network of Cancer Registries survey among 161 population-based cancer registries during 2010-2012.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.30132

21 January 2018

Use of 70-gene signature to predict prognosis of patients with node-negative breast cancer: a prospective community-based feasibility study (RASTER).

1 reference

https://api.crossref.org/works/10.1002%2FIJC.30132

21 January 2018

National Institutes of Health Consensus Development Conference Statement: adjuvant therapy for breast cancer, November 1-3, 2000.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.30132

21 January 2018

Community-based use of chemotherapy and hormonal therapy for early-stage breast cancer: 1987-2000.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.30132

21 January 2018

The impact of Oncotype DX testing on breast cancer management and chemotherapy prescribing patterns in a tertiary referral centre

1 reference

https://api.crossref.org/works/10.1002%2FIJC.30132

21 January 2018

Influence of race, insurance, socioeconomic status, and hospital type on receipt of guideline-concordant adjuvant systemic therapy for locoregional breast cancers

1 reference

https://api.crossref.org/works/10.1002%2FIJC.30132

21 January 2018

Using a gene expression signature when controversy exists regarding the indication for adjuvant systemic treatment reduces the proportion of patients receiving adjuvant chemotherapy: a nationwide study.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.30132

21 January 2018

US Insurance Program's Experience With a Multigene Assay for Early-Stage Breast Cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.30132

21 January 2018

Adherence to treatment guidelines and survival in patients with early-stage breast cancer by age at diagnosis

1 reference

https://api.crossref.org/works/10.1002%2FIJC.30132

21 January 2018

Identifiers

10.1002/IJC.30132

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40808798&oldid=1907801595"